Location of Repository

Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues

By A C P Riddick, C J Shukla, C J Pennington, R Bass, R K Nuttall, A Hogan, K K Sethia, V Ellis, A T Collins, N J Maitland, R Y Ball and D R Edwards

Abstract

Extracellular proteases of the matrix metalloproteinase (MMP) and serine protease families participate in many aspects of tumour growth and metastasis. Using quantitative real-time RT–PCR analysis, we have undertaken a comprehensive survey of the expression of these enzymes and of their natural inhibitors in 44 cases of human prostate cancer and 23 benign prostate specimens. We found increased expression of MMP10, 15, 24, 25 and 26, urokinase plasminogen activator-receptor (uPAR) and plasminogen activator inhibitor-1 (PAI1), and the newly characterised serine proteases hepsin and matriptase-1 (MTSP1) in malignant tissue compared to benign prostate tissue. In contrast, there was significantly decreased expression of MMP2 and MMP23, maspin, and the protease inhibitors tissue inhibitor of metalloproteinase 3 (TIMP3), TIMP4 and RECK (reversion-inducing cysteine-rich protein with Kazal motifs) in the cancer specimens. The expression of MMP15 and MMP26 correlated positively with Gleason score, whereas TIMP3, TIMP4 and RECK expression correlated negatively with Gleason score. The cellular localisation of the expression of the deregulated genes was evaluated using primary malignant epithelial and stromal cell cultures derived from radical prostatectomy specimens. MMP10 and 25, hepsin, MTSP1 and maspin showed predominantly epithelial expression, whereas TIMP 3 and 4, RECK, MMP2 and 23, uPAR and PAI1 were produced primarily by stromal cells. These data provide the first comprehensive and quantitative analysis of the expression and localisation of MMPs and their inhibitors in human prostate cancer, leading to the identification of several genes involved in proteolysis as potential prognostic indicators, in particular hepsin, MTSP1, MMP26, PAI1, uPAR, MMP15, TIMP3, TIMP4, maspin and RECK

Topics: Molecular Diagnostics
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2361819
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles

    Preview

    Citations

    1. (2004). Cancer mortality in Europe, 1995–1999, and an overview of trends since
    2. (1997). Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4.
    3. (2003). Maspin functions as tumor suppressor by increasing cell adhesion to extracellular matrix in prostate tumor cells.
    4. (2000). Matrix metalloproteinases and their tissue inhibitors – expression, role and regulation in human malignant non-Hodgkin’s lymphomas. Leuk Lymphoma 39: 485–493 Kuittinen
    5. (2002). Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 3: 509–519
    6. (2003). Regulation of migration of primary prostate epithelial cells by secreted factors from prostate stromal cells. Exp Cell Res 288: 246–256 Zhao
    7. (2000). Res Clin Oncol 117: 144–150

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.